Continuous or repeated prolonged cisplatin infusions in children: A prospective study on ototoxicity, platinum concentrations, and standard serum parameters
Pediatric Blood & Cancer2005Vol. 47(2), pp. 183–193
Citations Over TimeTop 13% of 2005 papers
Claudia Lanvers‐Kaminsky, Barbara Krefeld, A. G. Dinnesen, Dirk Deuster, Eberhard Seifert, Gudrun Würthwein, Ulrich Jaehde, Anne Christin Pieck, Joachim Boos
Abstract
While continuous cisplatin infusions are less nephrotoxic than repeated prolonged infusions, we observed considerable ototoxicity in patients treated with continuous cisplatin infusions, which necessitates further evaluations on the tolerance of continuous cisplatin infusions in children.
Related Papers
- → An integrated view of cisplatin-induced nephrotoxicity and ototoxicity(2015)457 cited
- → Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies(2021)120 cited
- → Gstm1/Gstt1 is essential for reducing cisplatin ototoxicity in CBA/CaJ mice(2022)9 cited
- → Evaluation of nephrotoxicity and ototoxicity following amikacin administration once daily or every 48 hours in neonates(2022)12 cited
- Effect of cisplatin on ototoxicity and expression of caspase-3 in mouse cochlea(2009)